C.I. MEDICAL CO.,LTD., January-September (Third Quarter Cumulative) Ordinary Profit Decreases by 53%, July-September Ordinary Profit Decreases by 61%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Nov 12, 2024 3:30 pm JST Earnings

3540 C.I. MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

C.I. MEDICAL CO.,LTD. <3540> [TSE-S] announced its financial results after the market closed on November 12th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending December 2024 (January to September) significantly dropped by 53.3% from the same period last year to 1.28 billion yen. The progress rate against the 2.47 billion yen full-year plan was 51.9%, also falling below the five-year average of 78.1%.

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to December period (4Q) is expected to surge by 2.2 times that of the same period last year, reaching 1.19 billion yen.

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit significantly dropped to 314 million yen, a 60.7% decrease compared to the same period last year. The operating profit margin drastically worsened from 6.8% in the same period last year to 0.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	31,468	3,174	3,214	2,098	42.0	82.6	Nov 8, 2022	J-GAAP
Jan - Sep, 2023	33,648	2,548	2,752	1,739	34.8	83.5	Nov 13, 2023	J-GAAP
Jan - Sep, 2024	45,248	1,108	1,285	5,337	106.8	51.9	Nov 12, 2024	J-GAAP
YoY	+34.5%	-56.5%	-53.3%	+206.9%	+206.8%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2023	23,431	1,221	1,342	856	17.1	5.04	Feb 13, 2024	J-GAAP
Jul - Dec, 2024 Guidance	43,237	1,366	1,504	5,553	111.1	－	Nov 7, 2024	J-GAAP
YoY	+84.5%	+11.9%	+12.1%	+548.7%	+548.7%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	42,891	3,990	3,889	2,521	50.4	5.04	Feb 14, 2023	J-GAAP
Dec, 2023	45,628	2,989	3,295	2,082	41.7	5.04	Feb 13, 2024	J-GAAP
Dec, 2024 Guidance	67,553	2,349	2,475	6,130	122.6	－	Nov 7, 2024	J-GAAP
YoY	+48.1%	-21.4%	-24.9%	+194.4%	+194.4%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	11,451	780	799	513	10.3	6.8	Nov 13, 2023	J-GAAP
Oct - Dec, 2023	11,980	441	543	343	6.9	3.7	Feb 13, 2024	J-GAAP
Jan - Mar, 2024	11,946	407	407	247	5.0	3.4	May 14, 2024	J-GAAP
Apr - Jun, 2024	12,370	576	564	330	6.6	4.7	Aug 13, 2024	J-GAAP
Jul - Sep, 2024	20,932	125	314	4,760	95.2	0.6	Nov 12, 2024	J-GAAP
YoY	+82.8%	-84.0%	-60.7%	+827.9%	+828.0%